CODA Therapeutics Raises $19M
South San Francisco-based CODA Biotherapeutics has raised $19M in a Series A funding, led by Versant Ventures and MPM Capital, with participation from Astellas Venture Management and Novartis, the company said this week. The new startup--incubated by Versant Ventures and MPM Capital-says it is developing gene therapy techniques, around what it calls a "chemogenetic platform" which it says aims to control the activity of neurons and other cells to treat diseases.
posted on Thursday, September 13, 2018 (Link to more information)
Related companies:
Coda Automotive AKA Miles Electrical Vehicles
Related stories:
> Arete Therapeutics Raises $35M
> Nuon Therapeutics Raises $27M
> Lead Therapeutics Raises $17M
> Emerald Therapeutics Raises $13.5M For Robotic Wet Labs
> CytomX Therapeutics Raises $41M
silicontap.com Home